Cargando…
Utility of cell-free nucleic acid and circulating tumor cell analyses in prostate cancer
Prostate cancer is characterized by bone metastases and difficulty of objectively measuring disease burden. In this context, cell-free circulating tumor DNA (ctDNA) and circulating tumor cell (CTC) quantitation and genomic profiling afford the ability to noninvasively and serially monitor the tumor....
Autores principales: | Gourdin, Theodore, Sonpavde, Guru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5952476/ https://www.ncbi.nlm.nih.gov/pubmed/29578115 http://dx.doi.org/10.4103/aja.aja_1_18 |
Ejemplares similares
-
Circulating tumor cells and their role in prostate cancer
por: Maas, Moritz, et al.
Publicado: (2019) -
Circulating Biomarkers in Bladder Cancer
por: Nandagopal, Lakshminarayanan, et al.
Publicado: (2016) -
Nucleic Acids Analysis
por: Zhao, Yongxi, et al.
Publicado: (2020) -
Circulating Nucleic Acids in Plasma or Serum (CNAPS) as Prognostic and Predictive Markers in Patients with Solid Neoplasias
por: Goebel, Georg, et al.
Publicado: (2005) -
Circulating cell-free nucleic acids as prognostic and therapy predictive tools for metastatic castrate-resistant prostate cancer
por: Sobhani, Navid, et al.
Publicado: (2020)